MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Falls and frailty predicate escalating care needs in Parkinson’s disease

    B. Mohamed, C. Thomas, H. Shukla, S. Aithal (Cardiff, United Kingdom)

    Objective: Assess the prevalence of falls in Parkinson's disease and evaluate change in care needs and institutionalisation in this cohort over a 5 year follow-up…
  • 2016 International Congress

    Patient satisfaction with flexible botulinum toxin injection intervals – Preliminary results of a telephone survey

    C. Linder, S. Macher, E. Auff, T. Sycha (Vienna, Austria)

    Objective: To evaluate satisfaction with flexible injection intervals in patients receiving Botulinum toxin therapy at our outpatient clinic. Background: Botulinum toxin therapy (BoNT) for muscular…
  • 2016 International Congress

    Randomized controlled trial protocol: Balance training with rhythmical cues to improve and maintain balance control in Parkinson’s disease

    T.T.C. Capato, J. Tornai, V.F. Gianguiagi, R.R. Firmino, E.R. Barbosa, M.E. Piemonte (São Paulo, Brazil)

    Objective: Is to evaluate the effects of balance training with rhythmical(BRT) which is a motor program to improve balance associated with rhythmical auditory cues (RACs).…
  • 2016 International Congress

    Detailed evaluation of dyskinesias using multiple endpoints in a randomized, placebo-controlled trial of Parkinson’s disease patients with motor fluctuations

    C. Kenney, K. Kieburtz, W. Olanow, S. Bandak (San Francisco, CA, USA)

    Objective: To analyze all dyskinesia data from a Phase 2b trial of fluctuating Parkinson patients in order to understand the overall impact a study drug…
  • 2016 International Congress

    Deep brain stimulation effect on the quality of life of individuals with Parkinson’s disease

    A. Ayres, M. Ghisi, A.M. Freiry, B.S.F. Oliveira, A.F.S. Schuch, C.R.M. Rieder, M.R. Olchik (Porto Alegre, Brazil)

    Objective: To identify the perception of QOL in individuals with PD pre and post DBS. Background: The DBS is one type of effective treatment in…
  • 2016 International Congress

    Objectivisation of postural disorders in patients with Parkinson’s disease during the screening stage for DBS

    A.G. Buniak, I.P. Maryenko, S.A. Likhachev (Minsk, Belarus)

    Objective: Objectivisation of degree of postural disorders in PD patients during the screening stage for DBS. Background: The neurosurgical treatment of Parkinson's disease (PD) using…
  • 2016 International Congress

    Successful DBS: Doctors happy, patients not – Why?

    M.H. Strothjohann, B. Holzinger, G.A. Fuchs, F. Weber (Bad Camberg, Germany)

    Objective: Deep brain stimulation (DBS) in Parkinson's disease (PD) has been proven successful; however, not in all. Background: We report on 5 PD patients who…
  • 2016 International Congress

    Comparison of four DBS lead designs under voltage and current operating modes based on patient specific simulations

    F. Alonso, N. Göransson, P. Zsgimond, K. Wårdell (Linköping, Sweden)

    Objective: To quantitatively compare the spatial extension of the electric field generated by four different lead designs operated under voltage and current modes. Background: Conventional…
  • 2016 International Congress

    A prospective study of patients’ expectations in subthalamic nucleus deep brain stimulation for Parkinson’s disease

    N.R. Mundil, H.Y. Ling, H. Hasegawa, M. Samuel, K. Ashkan (London, United Kingdom)

    Objective: To prospectively assess the long-term outcome of subthalamic nucleus (STN) deep brain stimulation (DBS) and the relationship with patients' expectations and satisfaction. Background: Subthalamic…
  • 2016 International Congress

    Cognitive outcome in the patients with Parkinson’s disease one year after subthalamic implants in Taiwan

    Y.F. Chen, C.C. Chang, W.F. Chen, F.Y. Shih, M.Y. Lan, T.K. Lin, Y.F. Chen, Y.Y. Chang (Kaohsiung, Taiwan)

    Objective: To demonstrate cognitive outcome after subthalamic deep brain stimulation(DBS) in the patients with Parkinson's disease(PD) in Taiwan. Background: Deep brain stimulation of the subthalamic…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley